FeesSafety
Pluang+

Volition expands Nu.Q® Vet Feline Test to Japan, aiming for first affordable blood test for cat cancer.

Market News
16 Nov 2026, 23:22 WIB
PRNewsWire
View Source
Bullish
Volition expands Nu.Q® Vet Feline Test to Japan, aiming for first affordable blood test for cat cancer.

VolitionRx has expanded its supply agreement with Fujifilm Vet Systems in Japan to develop and use the Nu.Q® Vet Feline Test, targeting early detection of feline cancer through a simple blood test. This test aims to be the world's first affordable liquid biopsy for cats, addressing the challenge of diagnosing cancer early in felines, especially lymphoma, the most common type. With nearly nine million cats in Japan and growing demand from veterinarians, this expansion represents a significant revenue opportunity and a step toward routine cancer screening in pets. The test will be launched on Fujifilm's automated platform after further studies are completed.

VolitionRx's expansion of its contract with Fujifilm to include the Nu.Q® Vet Test for cats provides context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 03:31 WIB: out of 150 priced US health-sector stocks, 31 rose and 118 fell. Notable movers include RXRX at USD 2.90 with a 1-day change of -8.95% and 100% buy order activity, NTRA at USD 291.45 down 8.66% with 100% buy order activity, and ABEO at USD 2.61 up 7.85% with 60% buy order activity and a typical hold time of 22 days.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App